Capricor Therapeutics
CAPR on XNAS, Capricor Therapeutics Inc
Measures activity, not value. Not investment advice.
Shares sold short (30 Oct 2026)
18.8M
-5.5% vs the report before
Short interest, % of shares outstanding
32%
58.1M shares outstanding (9 Nov 2026)
Days to cover
7.4
short interest / daily volume
Short sale volume share (20 Nov 2026)
65%
1-year median 52%
Sharp changes
22
short interest spike
FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.
See the numbers
| 30 Oct 2026: 18.8M shares sold short, 7.4 days to cover |
| 15 Oct 2026: 19.9M shares sold short, 6.6 days to cover |
| 30 Sep 2026: 18.8M shares sold short, 4.5 days to cover |
| 15 Sep 2026: 19.7M shares sold short, 5.9 days to cover |
| 31 Aug 2026: 22.2M shares sold short, 2.0 days to cover |
| 14 Aug 2026: 17.8M shares sold short, 1.6 days to cover |
| 31 Jul 2026: 16.0M shares sold short, 2.1 days to cover |
| 15 Jul 2026: 15.6M shares sold short, 10.8 days to cover |
| 30 Jun 2026: 14.7M shares sold short, 7.4 days to cover |
| 15 Jun 2026: 11.7M shares sold short, 13.7 days to cover |
| 29 May 2026: 11.1M shares sold short, 14.3 days to cover |
| 15 May 2026: 10.9M shares sold short, 8.2 days to cover |
| 30 Apr 2026: 10.5M shares sold short, 12.7 days to cover |
| 15 Apr 2026: 10.0M shares sold short, 9.5 days to cover |
| 31 Mar 2026: 9.9M shares sold short, 6.7 days to cover |
| 13 Mar 2026: 7.3M shares sold short, 4.0 days to cover |
| 27 Feb 2026: 6.9M shares sold short, 5.8 days to cover |
| 13 Feb 2026: 6.6M shares sold short, 7.3 days to cover |
| 30 Jan 2026: 5.9M shares sold short, 4.9 days to cover |
| 15 Jan 2026: 5.1M shares sold short, 3.4 days to cover |
| 31 Dec 2025: 5.1M shares sold short, 4.6 days to cover |
| 15 Dec 2025: 5.0M shares sold short, 1.0 days to cover |
| 28 Nov 2025: 16.4M shares sold short, 7.2 days to cover |
| 14 Nov 2025: 14.2M shares sold short, 7.9 days to cover |
| 31 Oct 2025: 13.3M shares sold short, 10.8 days to cover |
| 15 Oct 2025: 12.2M shares sold short, 11.3 days to cover |
| 30 Sep 2025: 11.7M shares sold short, 7.2 days to cover |
| 15 Sep 2025: 12.1M shares sold short, 11.2 days to cover |
| 29 Aug 2025: 11.5M shares sold short, 8.5 days to cover |
| 15 Aug 2025: 11.4M shares sold short, 7.7 days to cover |
| 31 Jul 2025: 11.1M shares sold short, 4.9 days to cover |
| 15 Jul 2025: 9.8M shares sold short, 2.9 days to cover |
| 30 Jun 2025: 11.2M shares sold short, 2.5 days to cover |
| 13 Jun 2025: 10.2M shares sold short, 4.7 days to cover |
| 30 May 2025: 11.1M shares sold short, 5.1 days to cover |
| 15 May 2025: 13.8M shares sold short, 3.4 days to cover |
| 30 Apr 2025: 10.3M shares sold short, 7.5 days to cover |
| 15 Apr 2025: 10.7M shares sold short, 8.1 days to cover |
| 31 Mar 2025: 9.3M shares sold short, 5.5 days to cover |
| 14 Mar 2025: 9.1M shares sold short, 5.5 days to cover |
| 28 Feb 2025: 8.2M shares sold short, 6.6 days to cover |
| 14 Feb 2025: 8.2M shares sold short, 8.5 days to cover |
| 31 Jan 2025: 7.7M shares sold short, 10.9 days to cover |
| 15 Jan 2025: 7.6M shares sold short, 8.2 days to cover |
| 31 Dec 2024: 8.0M shares sold short, 6.0 days to cover |
| 13 Dec 2024: 5.6M shares sold short, 2.9 days to cover |
| 29 Nov 2024: 4.4M shares sold short, 3.9 days to cover |
| 15 Nov 2024: 3.8M shares sold short, 3.5 days to cover |
| 31 Oct 2024: 5.3M shares sold short, 2.8 days to cover |
| 15 Oct 2024: 6.2M shares sold short, 1.2 days to cover |
| 30 Sep 2024: 5.2M shares sold short, 1.0 days to cover |
| 13 Sep 2024: 7.5M shares sold short, 46.0 days to cover |
| 30 Aug 2024: 7.5M shares sold short, 29.7 days to cover |
| 15 Aug 2024: 7.0M shares sold short, 17.0 days to cover |
| 31 Jul 2024: 6.2M shares sold short, 22.8 days to cover |
| 15 Jul 2024: 5.9M shares sold short, 13.7 days to cover |
| 28 Jun 2024: 4.7M shares sold short, 6.0 days to cover |
| 14 Jun 2024: 4.5M shares sold short, 12.9 days to cover |
| 31 May 2024: 4.6M shares sold short, 10.8 days to cover |
| 15 May 2024: 4.2M shares sold short, 16.5 days to cover |
What the numbers say
- 18.8M shares sold short on 30 Oct 2026, 32% of shares outstanding, 7.4 days to cover; -5.5% on the report before (published by FINRA on 10 Nov 2026).
Every measure from this source
Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.
Sharp changes
22 in all loaded history, strongest first
Capricor Therapeutics had 3.2M shares sold short in the 15 Mar 2024 report, 9.1× the same report last year.
Same report last year: 353K; its normal report is 474K.
See the evidence
- This period
- 3.2M (the 15 Mar 2024 report)
- Normal report (median of 24 earlier)
- 474K
- Typical spread (median absolute deviation)
- 213K
- How far from its usual level
- +8.7
- Same report last year
- 353K
- History used
- 2,268 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Capricor Therapeutics had 2.7M shares sold short in the 29 Feb 2024 report, 8.0× the same report last year.
Same report last year: 338K; its normal report is 377K.
See the evidence
- This period
- 2.7M (the 29 Feb 2024 report)
- Normal report (median of 24 earlier)
- 377K
- Typical spread (median absolute deviation)
- 120K
- How far from its usual level
- +13.0
- Same report last year
- 338K
- History used
- 2,253 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Capricor Therapeutics had 2.7M shares sold short in the 12 Jan 2024 report, 7.8× the same report last year.
Same report last year: 343K; its normal report is 333K.
See the evidence
- This period
- 2.7M (the 12 Jan 2024 report)
- Normal report (median of 24 earlier)
- 333K
- Typical spread (median absolute deviation)
- 68K
- How far from its usual level
- +23.4
- Same report last year
- 343K
- History used
- 2,205 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Capricor Therapeutics had 2.7M shares sold short in the 31 Jan 2024 report, 8.2× the same report last year.
Same report last year: 328K; its normal report is 333K.
See the evidence
- This period
- 2.7M (the 31 Jan 2024 report)
- Normal report (median of 24 earlier)
- 333K
- Typical spread (median absolute deviation)
- 68K
- How far from its usual level
- +23.2
- Same report last year
- 328K
- History used
- 2,224 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Capricor Therapeutics had 2.7M shares sold short in the 15 Feb 2024 report, 8.6× the same report last year.
Same report last year: 311K; its normal report is 346K.
See the evidence
- This period
- 2.7M (the 15 Feb 2024 report)
- Normal report (median of 24 earlier)
- 346K
- Typical spread (median absolute deviation)
- 84K
- How far from its usual level
- +18.6
- Same report last year
- 311K
- History used
- 2,239 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Capricor Therapeutics had 2.4M shares sold short in the 29 Dec 2023 report, 6.9× the same report last year.
Same report last year: 341K; its normal report is 333K.
See the evidence
- This period
- 2.4M (the 29 Dec 2023 report)
- Normal report (median of 24 earlier)
- 333K
- Typical spread (median absolute deviation)
- 63K
- How far from its usual level
- +21.5
- Same report last year
- 341K
- History used
- 2,191 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.